Ольга Васильевна Ремнёва
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ольга Васильевна Ремнёва has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Olga V. Koliado
Altai State Medical University
9 shared publications - Ksenia Vl. Dmitrienko
Altai State Medical University
8 shared publications - Svetlana Dm. Yavorskaya
Altai State Medical University
8 shared publications - A. I. Gal'CHenko
Altai State Medical University
5 shared publications - Anastasia E. Chernova
Altai State Medical Universit
4 shared publications - Irina S. Ivanyuk
Altai State Medical University
4 shared publications
Latest Publications
- Open Access
- 22 March 2026
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 11 (1) , 82-91
Audit of maternal mortality in a large agricultural region of south Siberia
Aim. To audit the maternal mortality rate in the Altai Region, an agrarian region of southern Siberia, for the period 2015−2024 and assess the contribution of extragenital pathology and direct obstetric causes to its structure. Materials and methods. A retrospective comparative analysis of the dynamics and structure of causes of maternal mortality for the period 2015−2024 was carried out in the number of 58 sectional observations in the Altai Region, characterized by a large territory, a population density below average and a predominance of women of fertile age living in rural areas (40.2 %). Results. The maternal mortality rate in the large agricultural region of southern Siberia over the 10-year period under study was unstable. The sharp increase in its level in 2021 (73.7 per 100,000 live births) was due to COVID-19 and its consequences in the form of thromboembolic complications. The leading causes of maternal mortality in the post-pregnancy period are complications of cardiovascular diseases, HIV- infection, and cases of direct obstetric causes are determined by the social factor. Conclusion. To achieve the goals of sustainable development at the regional level, interdisciplinary interaction and coordination of the efforts of specialized specialists for the correction of cardiovascular pathology, HIV-infection, effective social and psychological work with patients at high social risk is necessary.
- 22 March 2026
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 11 (1) , 82-91
Open AccessAudit of maternal mortality in a large agricultural region of south Siberia
Aim. To audit the maternal mortality rate in the Altai Region, an agrarian region of southern Siberia, for the period 2015−2024 and assess the contribution of extragenital pathology and direct obstetric causes to its structure. Materials and methods. A retrospective comparative analysis of the dynamics and structure of causes of maternal mortality for the period 2015−2024 was carried out in the number of 58 sectional observations in the Altai Region, characterized by a large territory, a population density below average and a predominance of women of fertile age living in rural areas (40.2 %). Results. The maternal mortality rate in the large agricultural region of southern Siberia over the 10-year period under study was unstable. The sharp increase in its level in 2021 (73.7 per 100,000 live births) was due to COVID-19 and its consequences in the form of thromboembolic complications. The leading causes of maternal mortality in the post-pregnancy period are complications of cardiovascular diseases, HIV- infection, and cases of direct obstetric causes are determined by the social factor. Conclusion. To achieve the goals of sustainable development at the regional level, interdisciplinary interaction and coordination of the efforts of specialized specialists for the correction of cardiovascular pathology, HIV-infection, effective social and psychological work with patients at high social risk is necessary.
- 11 March 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 26 (1) , 42-50
Placenta-associated complications as risk factors for induction of preterm labor: perinatal aspects
Objective. To determine risk factors for induction of preterm labor and the severity of oxidative stress in fetuses undergoing abdominal delivery due to placenta-associated complications. Material and methods. A total of 152 pregnant women were examined and divided into two groups. The study group included 102 patients with abdominal preterm labor induced by placenta-associated complications. The comparison group consisted of 50 pregnant women who had a planned term cesarean section for obstetric indications with satisfactory fetal condition. The practical significance of malondialdehyde, matrix metalloproteinases of the 1st and 9th families, and their tissue inhibitor (TIMP-1) was studied as predictors of cerebral disorders in preterm fetuses/newborns during induction of preterm labor due to life-threatening conditions for the mother and fetus. Results. The following clinical and anamnestic risk factors were established for induction of preterm labor in pregnant women with developed placenta-associated complications: hypertensive disorders (odds ratio, OR, 13.9); chronic pelvic inflammatory diseases; genital infections (OR, 4.06); urinary tract infections (OR, 3.3); and a history of two or more artificial abortions (OR, 3.2). Malondialdehyde, matrix metalloproteinases of families 1 and 9, and their tissue inhibitor, TIMP-1, were identified in biological fluids as laboratory predictors of the severity of cerebral disorders in premature fetuses/newborns. Conclusion. Predicting the severity of cerebral disorders in fetuses during preterm abdominal delivery by determining the concentration of malondialdehyde in amniotic fluid, the activity of matrix metalloproteinases of families 1 and 9, and their tissue inhibitor, as well as their early detection in cord blood, allows for the initiation of rehabilitation measures immediately after birth. Identifying preconception clinical and anamnestic risk factors for induced preterm labor due to placenta-associated complications allows for a differentiated approach to planning subsequent pregnancies.
- 11 March 2026
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 26 (1) , 42-50
Placenta-associated complications as risk factors for induction of preterm labor: perinatal aspects
Objective. To determine risk factors for induction of preterm labor and the severity of oxidative stress in fetuses undergoing abdominal delivery due to placenta-associated complications. Material and methods. A total of 152 pregnant women were examined and divided into two groups. The study group included 102 patients with abdominal preterm labor induced by placenta-associated complications. The comparison group consisted of 50 pregnant women who had a planned term cesarean section for obstetric indications with satisfactory fetal condition. The practical significance of malondialdehyde, matrix metalloproteinases of the 1st and 9th families, and their tissue inhibitor (TIMP-1) was studied as predictors of cerebral disorders in preterm fetuses/newborns during induction of preterm labor due to life-threatening conditions for the mother and fetus. Results. The following clinical and anamnestic risk factors were established for induction of preterm labor in pregnant women with developed placenta-associated complications: hypertensive disorders (odds ratio, OR, 13.9); chronic pelvic inflammatory diseases; genital infections (OR, 4.06); urinary tract infections (OR, 3.3); and a history of two or more artificial abortions (OR, 3.2). Malondialdehyde, matrix metalloproteinases of families 1 and 9, and their tissue inhibitor, TIMP-1, were identified in biological fluids as laboratory predictors of the severity of cerebral disorders in premature fetuses/newborns. Conclusion. Predicting the severity of cerebral disorders in fetuses during preterm abdominal delivery by determining the concentration of malondialdehyde in amniotic fluid, the activity of matrix metalloproteinases of families 1 and 9, and their tissue inhibitor, as well as their early detection in cord blood, allows for the initiation of rehabilitation measures immediately after birth. Identifying preconception clinical and anamnestic risk factors for induced preterm labor due to placenta-associated complications allows for a differentiated approach to planning subsequent pregnancies.
- 1 January 2026
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 14 (3)
Comorbidity in the thanatogenesis of maternal mortality in the Altai Krai
- 1 January 2026
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 14 (3)
Comorbidity in the thanatogenesis of maternal mortality in the Altai Krai
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (3) , 131-138
EXPLORING THE POTENTIAL OF A BIOLOGICALLY ACTIVE FOOD SUPPLEMENT TO RESTORE THE FUNCTIONAL STATE OF THE MAMMARY GLANDS AND ALLEVIATE SYMPTOMS OF PREMENSTRUAL SYNDROME
Women of reproductive age require effective and safe treatments for the prevention of breast diseases, including benign mammary dysplasia (BMD), as well as for alleviating symptoms associated with premenstrual syndrome (PMS). Objective. This study aims to organize information regarding the pharmacological effects and safety profiles of plant extracts utilized in the management of breast diseases, PMS, hormonal imbalances, and functional disorders of the genitourinary system. Materials and Methods. A comprehensive search was performed for studies examining the properties of cinnamon rose extract, bearberry extract, oregano extract, milk thistle extract, ortilia secunda extract, sweetvetch extract, purple echinacea extract, and their combinations. This search utilized the validated bibliographic database of the US National Library of Medicine PubMed, as well as the Russian scientific online libraries eLibrary and Cyberleninka, and the websites of prominent regulatory agencies. Results. The plant extracts incorporated in dietary supplements (DS) exhibit antiproliferative, antitumor, antioxidant, analgesic, anti-inflammatory, and antiseptic properties, as evidenced by both in vitro and in vivo studies. The concentrations of arbutin, flavonols (expressed as rutin), flavonolignans, hydroxycinnamic acids, and tannins (expressed as tannin) present in the daily dosage of the DS are deemed safe for human consumption. Conclusion. The synergistic application of cinnamon rose extract, bearberry extract, oregano extract, milk thistle extract, ortilia secunda extract, sweetvetch extract, and purple echinacea extract may yield beneficial effects for women suffering from bone mineral density (BMD) issues and premenstrual syndrome (PMS) by addressing the underlying pathogenesis and symptoms associated with these conditions. Additionally, it may enhance the functional status of the genitourinary system and improve hormonal profiles. When utilized in accordance with the provided guidelines, this dietary supplement demonstrates a favorable safety profile.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (3) , 131-138
EXPLORING THE POTENTIAL OF A BIOLOGICALLY ACTIVE FOOD SUPPLEMENT TO RESTORE THE FUNCTIONAL STATE OF THE MAMMARY GLANDS AND ALLEVIATE SYMPTOMS OF PREMENSTRUAL SYNDROME
Women of reproductive age require effective and safe treatments for the prevention of breast diseases, including benign mammary dysplasia (BMD), as well as for alleviating symptoms associated with premenstrual syndrome (PMS). Objective. This study aims to organize information regarding the pharmacological effects and safety profiles of plant extracts utilized in the management of breast diseases, PMS, hormonal imbalances, and functional disorders of the genitourinary system. Materials and Methods. A comprehensive search was performed for studies examining the properties of cinnamon rose extract, bearberry extract, oregano extract, milk thistle extract, ortilia secunda extract, sweetvetch extract, purple echinacea extract, and their combinations. This search utilized the validated bibliographic database of the US National Library of Medicine PubMed, as well as the Russian scientific online libraries eLibrary and Cyberleninka, and the websites of prominent regulatory agencies. Results. The plant extracts incorporated in dietary supplements (DS) exhibit antiproliferative, antitumor, antioxidant, analgesic, anti-inflammatory, and antiseptic properties, as evidenced by both in vitro and in vivo studies. The concentrations of arbutin, flavonols (expressed as rutin), flavonolignans, hydroxycinnamic acids, and tannins (expressed as tannin) present in the daily dosage of the DS are deemed safe for human consumption. Conclusion. The synergistic application of cinnamon rose extract, bearberry extract, oregano extract, milk thistle extract, ortilia secunda extract, sweetvetch extract, and purple echinacea extract may yield beneficial effects for women suffering from bone mineral density (BMD) issues and premenstrual syndrome (PMS) by addressing the underlying pathogenesis and symptoms associated with these conditions. Additionally, it may enhance the functional status of the genitourinary system and improve hormonal profiles. When utilized in accordance with the provided guidelines, this dietary supplement demonstrates a favorable safety profile.
- 1 January 2026
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 14 (1)
Analysis of critical obstetric conditions in the large Siberian agrarian-industrial region
- 1 January 2026
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 14 (1)
Analysis of critical obstetric conditions in the large Siberian agrarian-industrial region
- Open Access
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (1) , 52-57
EFFICACY OF BIOACTIVE HERBAL PREPARATIONS IN PATIENTS WITH ULTRASOUND SIGNS OF BENIGN BREAST DYSPLASIA AND MASTALGIA
Objective. To evaluate the clinical efficacy and safety of a herbal drug combination manufactured by Alfit Plus compony (Fitol-1 Mastoprof capsules + Mastokrel cream gel) as monotherapy in reproductive-aged patients with ultrasound signs of benign breast dysplasia and mastalgia. Materials and Methods. A single-center, open, prospective, pre-post comparative study was conducted. The study included 30 patients aged 21 to 45 years with mastalgia (VAS intensity >40 mm) and ultrasound signs of benign breast dysplasia corresponding to BIRADS category 2. Exclusion criteria were BIRADS ≥3, the use of hormonal medications, and severe somatic pathology. At baseline and after 3 months, the following parameters were evaluated: complaints, pain intensity using VAS, breast ultrasound data (on days 7–9 of the menstrual cycle), anthropometric measurements, blood pressure, and heart rate. Patients received Fitol-1 Mastoprof (1 capsule twice daily, per os) and Mastokrel cream gel (applied to the breasts morning and evening) for 3 months. Statistical analysis was performed using paired Student's t-test and χ² test (significance set at p<0.05). Results. The mean age was 37.0 ± 7.29 years; normal menstrual cycle was present in 70.0% of the cases. The baseline intensity of mastalgia according to VAS was – 53,5 ± 15,258 mm. Ultrasound revealed diffuse changes in all patients, small cysts (3–7 mm) in 60.0%, and duct ectasia in 15.0%. After 3 months of therapy, mastalgia persisted in only 6 patients (20.0%) with a reduction in intensity to 16, 66 ± 3, 47 mm (p <0.001); the mean VAS score for the entire group was 3.3 ± 0.42 mm. Galactorrhea was not observed in any patient. Ultrasound findings improved in 76.6% of cases (p <0.001): cysts regressed in 12 of 18 patients, and duct ectasia persisted in only 1 of 15 patients. No adverse events were reported and all patients noted the convenience of the treatment regimen. Conclusion. Three-month monotherapy with the combination of Fitol-1 Mastoprof (capsules) and Mastokrel cream gel in reproductive-aged patients with benign breast dysplasia allows complete resolution or significant reduction of mastalgia in 80% of cases, improves ultrasound findings in 76.6% and is not associated with adverse events. The results obtained support the use of this combination patients with mastalgia and benign breast dysplasia.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (1) , 52-57
Open AccessEFFICACY OF BIOACTIVE HERBAL PREPARATIONS IN PATIENTS WITH ULTRASOUND SIGNS OF BENIGN BREAST DYSPLASIA AND MASTALGIA
Objective. To evaluate the clinical efficacy and safety of a herbal drug combination manufactured by Alfit Plus compony (Fitol-1 Mastoprof capsules + Mastokrel cream gel) as monotherapy in reproductive-aged patients with ultrasound signs of benign breast dysplasia and mastalgia. Materials and Methods. A single-center, open, prospective, pre-post comparative study was conducted. The study included 30 patients aged 21 to 45 years with mastalgia (VAS intensity >40 mm) and ultrasound signs of benign breast dysplasia corresponding to BIRADS category 2. Exclusion criteria were BIRADS ≥3, the use of hormonal medications, and severe somatic pathology. At baseline and after 3 months, the following parameters were evaluated: complaints, pain intensity using VAS, breast ultrasound data (on days 7–9 of the menstrual cycle), anthropometric measurements, blood pressure, and heart rate. Patients received Fitol-1 Mastoprof (1 capsule twice daily, per os) and Mastokrel cream gel (applied to the breasts morning and evening) for 3 months. Statistical analysis was performed using paired Student's t-test and χ² test (significance set at p<0.05). Results. The mean age was 37.0 ± 7.29 years; normal menstrual cycle was present in 70.0% of the cases. The baseline intensity of mastalgia according to VAS was – 53,5 ± 15,258 mm. Ultrasound revealed diffuse changes in all patients, small cysts (3–7 mm) in 60.0%, and duct ectasia in 15.0%. After 3 months of therapy, mastalgia persisted in only 6 patients (20.0%) with a reduction in intensity to 16, 66 ± 3, 47 mm (p <0.001); the mean VAS score for the entire group was 3.3 ± 0.42 mm. Galactorrhea was not observed in any patient. Ultrasound findings improved in 76.6% of cases (p <0.001): cysts regressed in 12 of 18 patients, and duct ectasia persisted in only 1 of 15 patients. No adverse events were reported and all patients noted the convenience of the treatment regimen. Conclusion. Three-month monotherapy with the combination of Fitol-1 Mastoprof (capsules) and Mastokrel cream gel in reproductive-aged patients with benign breast dysplasia allows complete resolution or significant reduction of mastalgia in 80% of cases, improves ultrasound findings in 76.6% and is not associated with adverse events. The results obtained support the use of this combination patients with mastalgia and benign breast dysplasia.
- Open Access
- 1 July 2025
- Published by Grodno State Medical University in Journal of the Grodno State Medical University
- Vol. 23 (3) , 221-226
CLINICAL MANIFESTATIONS OF PREMENSTRUAL SYNDROME IN FEMALE STUDENTS
Background. One of the most common problems of menstrual cycle disorders in women in countries all over the world is premenstrual syndrome (PMS). The aim of the study is to establish the frequency and dominant symptoms of premenstrual syndrome in female students of the medical university of the Altai Territory. Material and methods. A continuous blinded electronic survey (Google form) of 152 female medical students of the 4th-5th years was conducted. The author's questionnaire included a premenstrual syndrome validated questionnaire from the Royal College of Obstetricians and Gynecologists. Results. Premenstrual syndrome was revealed in 77.6% of respondents. The most common symptoms were decreased mood (84.2%), decreased performance (65.1%), anxiety and/or muscle tension (83.6%), mastalgia/mastodynia (73.6%). The majority of respondents noted the above-mentioned pathological symptoms and a significant decrease in quality of life and performance 7-10 days before the onset of menstruation (72.0%). Moderate premenstrual syndrome was detected in 15.3% of cases. The percentage of female students seeking medical help because of premenstrual syndrome was 39.5%. Conclusions. The examined female medical students are a risk group for developing PMS.
- 1 July 2025
- Published by Grodno State Medical University in Journal of the Grodno State Medical University
- Vol. 23 (3) , 221-226
Open AccessCLINICAL MANIFESTATIONS OF PREMENSTRUAL SYNDROME IN FEMALE STUDENTS
Background. One of the most common problems of menstrual cycle disorders in women in countries all over the world is premenstrual syndrome (PMS). The aim of the study is to establish the frequency and dominant symptoms of premenstrual syndrome in female students of the medical university of the Altai Territory. Material and methods. A continuous blinded electronic survey (Google form) of 152 female medical students of the 4th-5th years was conducted. The author's questionnaire included a premenstrual syndrome validated questionnaire from the Royal College of Obstetricians and Gynecologists. Results. Premenstrual syndrome was revealed in 77.6% of respondents. The most common symptoms were decreased mood (84.2%), decreased performance (65.1%), anxiety and/or muscle tension (83.6%), mastalgia/mastodynia (73.6%). The majority of respondents noted the above-mentioned pathological symptoms and a significant decrease in quality of life and performance 7-10 days before the onset of menstruation (72.0%). Moderate premenstrual syndrome was detected in 15.3% of cases. The percentage of female students seeking medical help because of premenstrual syndrome was 39.5%. Conclusions. The examined female medical students are a risk group for developing PMS.
- Open Access
- 8 May 2025
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 46-57
Assessment of he prevalence of pelvic floor dysfunction in women of reproductive age based on a questionnaire
The aim of the research. To determine the prevalence of symptoms of pelvic floor dysfunction in women of Barnaul and their relationship with socio-demographic and clinical-anamnestic factors.Materials and methods. The study included 400 women aged 18–45 years living in the city of Barnaul. The study was conducted using the questionnaires PFDI 20 (Pelvic Floor Distress Inventory Questionnaire) and FSFI 19 (Female sexual function index). A comparative analysis of socio-demographic and clinical data of patients with symptoms of dysfunction and normal pelvic floor function was carried out.Results. Symptoms of pelvic floor dysfunction are registered in 82% of women. Symptoms of pelvic organ prolapse are noted by 61% of women, urinary disorders – 68%, colorectal-anal symptoms are found in 59,5% of women. Symptoms of sexual dysfunction are registered in 60% of women. A relationship was found between the presence of pelvic floor dysfunction symptoms and a history of vaginal delivery (p = 0,005), a history of precipitous labor (p=0.02), delivery of a large fetus (p=0.000), perineal trauma during childbirth (p=0.000), abortions (p=0.001), adenomyosis (p=0.008), the presence of POP in first-degree relatives (p=0.001), chronic gastritis (p=0.002), constipation (p=0.000) and varicose veins of the lower extremities (p=0.05). Sexual dysfunction is statistically significantly more often recorded in women with a BMI of more than 25 kg/m2 (p=0.02).Conclusions. Symptoms of pelvic floor dysfunction are highly prevalent among women of reproductive age. The relationship between the presence of pelvic floor dysfunction symptoms and socio-demographic and clinical-anamnestic factors women is determined.
- 8 May 2025
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 1,p. 46-57
Open AccessAssessment of he prevalence of pelvic floor dysfunction in women of reproductive age based on a questionnaire
The aim of the research. To determine the prevalence of symptoms of pelvic floor dysfunction in women of Barnaul and their relationship with socio-demographic and clinical-anamnestic factors.Materials and methods. The study included 400 women aged 18–45 years living in the city of Barnaul. The study was conducted using the questionnaires PFDI 20 (Pelvic Floor Distress Inventory Questionnaire) and FSFI 19 (Female sexual function index). A comparative analysis of socio-demographic and clinical data of patients with symptoms of dysfunction and normal pelvic floor function was carried out.Results. Symptoms of pelvic floor dysfunction are registered in 82% of women. Symptoms of pelvic organ prolapse are noted by 61% of women, urinary disorders – 68%, colorectal-anal symptoms are found in 59,5% of women. Symptoms of sexual dysfunction are registered in 60% of women. A relationship was found between the presence of pelvic floor dysfunction symptoms and a history of vaginal delivery (p = 0,005), a history of precipitous labor (p=0.02), delivery of a large fetus (p=0.000), perineal trauma during childbirth (p=0.000), abortions (p=0.001), adenomyosis (p=0.008), the presence of POP in first-degree relatives (p=0.001), chronic gastritis (p=0.002), constipation (p=0.000) and varicose veins of the lower extremities (p=0.05). Sexual dysfunction is statistically significantly more often recorded in women with a BMI of more than 25 kg/m2 (p=0.02).Conclusions. Symptoms of pelvic floor dysfunction are highly prevalent among women of reproductive age. The relationship between the presence of pelvic floor dysfunction symptoms and socio-demographic and clinical-anamnestic factors women is determined.
- Open Access
- 25 March 2025
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 10 (1) , 47-55
Comparison of pregnancy course and outcomes in patients with uterine fibroids following uterine artery embolisation or myomectomy
Aim. To determine the optimal surgical treatment for uterine fibroids in patients with unfulfilled reproductive through the analysis of pregnancy course and outcomes following uterine artery embolization (UAE) and myomectomy.Materials and Methods. The study assessed pregnancy course and outcomes, as well as neonatal conditions, in 147 patients including those who: 1) underwent UAE; 2) underwent myomectomy; 3) had untreated uterine fibroids; 4) did not have uterine fibroids. Data collection was conducted retrospectively by reviewing medical records, including case histories, pregnancy and delivery records, and newborn histories.Results. There have been significant differences in pregnancy complications and delivery methods among the women who received distinct surgical treatments for uterine fibroids (myomectomy vs. UAE). In the third trimester, placental abnormalities were more frequent after UAE (12.5%) that after myomectomy (2.9%) but cesarian delivery was performed twice as low (47.0% vs. 94.3, respectively). Subsequent pregnancy risks were higher among the patients who had undergone myomectomy, as 50% of them experienced fibroid recurrence during the pregnancy and there were scars on the uterus as a result of myomectomy and cesarean section.Conclusion. No new fibroid nodules as well as growth or vascularization of existing fibroids were observed after UAE, suggesting that it can be considered as a preferred treatment option, particularly for women who have not yet completed their reproductive plans.
- 25 March 2025
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 10 (1) , 47-55
Open AccessComparison of pregnancy course and outcomes in patients with uterine fibroids following uterine artery embolisation or myomectomy
Aim. To determine the optimal surgical treatment for uterine fibroids in patients with unfulfilled reproductive through the analysis of pregnancy course and outcomes following uterine artery embolization (UAE) and myomectomy.Materials and Methods. The study assessed pregnancy course and outcomes, as well as neonatal conditions, in 147 patients including those who: 1) underwent UAE; 2) underwent myomectomy; 3) had untreated uterine fibroids; 4) did not have uterine fibroids. Data collection was conducted retrospectively by reviewing medical records, including case histories, pregnancy and delivery records, and newborn histories.Results. There have been significant differences in pregnancy complications and delivery methods among the women who received distinct surgical treatments for uterine fibroids (myomectomy vs. UAE). In the third trimester, placental abnormalities were more frequent after UAE (12.5%) that after myomectomy (2.9%) but cesarian delivery was performed twice as low (47.0% vs. 94.3, respectively). Subsequent pregnancy risks were higher among the patients who had undergone myomectomy, as 50% of them experienced fibroid recurrence during the pregnancy and there were scars on the uterus as a result of myomectomy and cesarean section.Conclusion. No new fibroid nodules as well as growth or vascularization of existing fibroids were observed after UAE, suggesting that it can be considered as a preferred treatment option, particularly for women who have not yet completed their reproductive plans.